Embecta’s disposable pump for insulin delivery cleared by FDA

Embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system. Indicated for adults who require insulin to manage diabetes, including both type 1 and type 2, the system includes a tubeless patch pump design with a 300-unit insulin reservoir that was informed by feedback from people with T2D and their healthcare providers. Embecta’s patch pump development program also includes plans for a closed-loop version including an insulin-dosing algorithm in a future FDA submission.